News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

CoorsTek Recognized as a US Best Managed Company

CoorsTek

CoorsTek is proud to announce it has been selected as a 2022 US Best Managed Company. Sponsored by Deloitte Private and The Wall Street Journal, the program recognizes outstanding U.S. private companies and the achievements of their management teams. The 2022 designees are U.S. private companies that have demonstrated excellence in strategic planning and execution, a commitment to their people and fostering a dynamic, resilient culture, as well as strong financials. This year’s designees continued to propel their businesses forward by prioritizing purpose, investing in their workforces, and demonstrating their commitment to diversity, equity and inclusion. “We are honored to be recognized as a best managed company again this year,” said Jonathan Coors, CEO of CoorsTek. “This award is a tribute to the dedication and resiliency of our CoorsTek team members across the globe over the past several years. It also speaks to the strong values that guide our daily activities and actions, and our focus on delivering essential products and services to the marketplace.” Applicants are evaluated and selected by a panel of external judges focused on assessing hallmarks of excellence in four key areas: strategy, ability to execute, corporate culture and governance/financial performance. They join a global ecosystem of honorees from more than 40 countries recognized by the Best Managed Companies program. About The Best Managed Companies Program The Best Managed Companies program is a mark of excellence for private companies. U.S. designees have revenues of at least $250 million. Hundreds of private companies around the world have competed for this designation in their respective countries through a rigorous and independent process that evaluates four key criteria in their management skills and practices — strategy, execution, culture and governance/financials. U.S. program sponsors are Deloitte Private and The Wall Street Journal. For more information, visit www.usbestmanagedcompanies.com. Please see www.deloitte.com/us/about for a detailed description of our legal structure. About CoorsTek Founded in 1910 and headquartered in Golden, Colorado, CoorsTek is a fifth-generation, family owned and operated global manufacturer of engineered ceramics. By utilizing over half of the world’s known elements in our material formulations, we deliver unique solutions to our diverse customer base by leveraging ceramic properties. With more than 30 facilities across three continents, five million square feet in manufacturing space, and more than 6,000 team members, we are the partner of choice in engineered ceramics. CoorsTek makes the world measurably better by providing customers with amazing solutions, serving customers in numerous industries including semiconductor, aerospace, automotive, medical, energy and many others around the world. For more information about the company and its products please visit our website at www.coorstek.com. Contact Details CoorsTek Nancy Fullerton +1 517-304-4695 nfullerton@coorstek.com Company Website https://www.coorstek.com

May 11, 2022 03:52 PM Eastern Daylight Time

Article thumbnail News Release

DermTech Helps Detect Skin Cancer Through a Smart Sticker Instead of a Scalpel

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/9SD9aKn3328 Would it surprise you to know that one in five Americans develop skin cancer by the age of 70? In fact, more than two people die of skin cancer in the U.S. every hour. It is one of the deadliest forms of skin cancer and one of the most common cancers diagnosed in the U.S. Because of the nation-wide closures of dermatology offices during the pandemic, there was a significant delay in routine cancer screening which impaired referrals for preliminary cancer diagnoses. This means there is a potential backlog of undiagnosed skin cancers. Even prior to the pandemic, only 16 percent of Americans ages 18-29 surveyed in a 2018 study stated that they visited a dermatologist’s office in the past 12 months. What if there were an innovative and painless ways to get your moles checked at home via a telehealth appointment and under clinician supervision? DermTech’s reliable and patient-friendly test, the DermTech Melanoma Test, enhances early melanoma detection by accurately ruling out melanoma. It uses a non-invasive Smart Sticker to gently lift skin cells from the surface of the skin, which are tested for the presence of genomic markers associated with melanoma. A negative test result means there is greater than 99% probability that the mole is not melanoma. The Smart Sticker is simply pressed onto the spot, lifted off and then sent to DermTech’s lab. Patients can access the DermTech Melanoma Test at dermatologists’ offices, through certain primary care providers or remotely via telehealth in 44 states. For more information visit: https://dermtech.com/ Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

May 10, 2022 01:30 PM Eastern Daylight Time

Video
Article thumbnail News Release

Dartmouth Innovation & Technology Festival Celebrates Completion of Dartmouth’s West End District Focused on Solving the World’s “Wicked Problems”

Dartmouth

With $500 Million in capital and programming investments, expanded district combines Dartmouth’s liberal arts focus with entrepreneurial spirit, technological and scientific expertise to create future leaders; Festival program will include a range of speakers and topics focused on creating a sustainable, equitable future Former Dartmouth president, John Sloan Dickey, famously implored students to apply their education for the benefit of humankind—because “there is nothing wrong with the world that better human beings cannot fix.” That’s the spirit behind the recently completed West End District at Dartmouth, which will be celebrated at the Dartmouth Innovation & Technology Festival, May 12-14, 2022. The festival will gather leading alumni, global technology experts, public policy leaders, faculty, and students for provocative discussions about innovation, collaboration, and the art of the possible. Dartmouth President Philip J. Hanlon said of the West End District, “Solving society’s greatest challenges requires that students, faculty, and staff have the necessary cutting-edge infrastructure to do their best work." Dartmouth’s West End began with the idea that organizing scholarship by research areas, rather than by departments, works better to break down the silos that have kept scientists, business leaders, and innovators looking at complex problems only from within their own disciplines. Interdisciplinary, inter-school, and intergenerational collaboration will prepare future leaders to tackle the world’s most wicked issues. The West End District includes the Tuck School of Business, Thayer School of Engineering, and two new state-of-the-art buildings, the Arthur L. Irving Institute for Energy and Society and the Class of 1982 Engineering and Computer Science Center, which houses the Department of Computer Science, Magnuson Center for Entrepreneurship, and the Digital Applied Learning and Innovation Lab. Key Points The West End District changes the way teaching and learning happens. It allows faculty and students to think systemically and holistically about society’s challenges—and is where big ideas become bold realities at the intersections of science, technology, business, and the liberal arts. The West End was a top priority of Dartmouth’s The Call to Lead campaign and is the largest building project in Dartmouth’s 253-year history. The Dartmouth Innovation & Technology Festival will feature a range of events, including: The presentation of the first annual McGuire Family Prize for Societal Impact, awarded to Jason McLellan, a structural biologist whose groundbreaking coronavirus research conducted at the Geisel School of Medicine laid the foundation for COVID-19 vaccines that have saved countless lives. Keynote and panel conversations about a range of topics, including sustainability, whether crypto currency can deliver long-term value, women’s health, artificial intelligence, transportation, and increasing diversity in STEM. Interactive experiences in makerspaces led by faculty and Dartmouth students. About Dartmouth Founded in 1769, Dartmouth is a member of the Ivy League and consistently ranks among the world’s greatest academic institutions. Dartmouth has forged a singular identity for combining its deep commitment to outstanding undergraduate liberal arts and graduate education with distinguished research and scholarship in the Arts and Sciences and its four leading graduate schools—the Geisel School of Medicine, the Guarini School of Graduate and Advanced Studies, Thayer School of Engineering, and the Tuck School of Business. Contact Details Racepoint Global Madison Everts dartmouth@racepointglobal.com

May 10, 2022 01:22 PM Eastern Daylight Time

Image
Article thumbnail News Release

The Hidden Cost of Debt on Your Mental Health

YourUpdateTV

May is Mental Health Awareness Month, and with 80% of Americans in debt amid inflation and rising interest rates one of the biggest factors impacting our mental health that not enough people are talking about is financial debt. Recently, licensed clinical psychologist and National Debt Relief Financial Wellness Board Member, Dr. Regine Muradian conducted a satellite media tour to discuss why self-care is important during challenging financial times. A video accompanying this announcement is available at: https://youtu.be/h_cczQ9fKS8 A recent survey by National Debt Relief sought to uncover “The Hidden Cost of Debt” to understand the spiraling impact of debt on mental and physical health. The national survey of two thousand Americans revealed a hunger to have a game plan in place so they feel confident in their ability to tackle debt while living their life mentally, physically and financially well. National Debt Relief has helped over 450,000 clients settle their debt by working with creditors and banks to negotiate down the total amount owed in as little as 24-48 months. What’s more, 95% of clients are in a better financial situation, and they are 4x more likely to reach their financial goals and save after one month of completing National Debt Relief’s program. Some of the survey findings include: 7 in 10 people feel like a black cloud hangs over them when they have to pay a bill or loan People lose 200 hours of sleep per year over their debt & have 3 debt nightmares a week 3 in 5 Americans have considered putting off marriage to avoid inheriting their partner’s debt 54% believe having a partner who is in debt is a major reason to get a divorce 69% of respondents said being in debt has made them withdraw from the things they love Continuing to look at the future, 3 in 4 want to pay off all debt so their children won’t have to suffer Nearly three-quarters of those polled wish there were tools and resources available to help them when they were at their worst in debt ( 73% ). While it is very important to deal with the monetary side of debt, it’s also critical to understand how our finances can have a toll on mental health and relationships with friends, relatives, and spouses. Dr. Muradian shares her tips and insights on the best ways to cope with and overcome the hidden costs and burden of debt: Establishing a plan for getting out of debt and get back in control Prioritizing self-care practices through the journey to support mental health, such as: Reframing thoughts by shifting from “I’m in debt” to “I have a plan to get out of debt”. Doing one activity each day for oneself like exercising or reading Having transparent conversations with loved ones (partner, spouse, family or friends) to avoid feelings of isolation. To get started on the path to financial stability, visit nationaldebtrelief.com or call 800-927-6955 for a free consultation. About Dr. Regine Muradian: Dr. Regine Muradian is a licensed clinical psychologist, children’s author, speaker, consultant and mental health advocate. In her clinical practice, Dr. Muradian works with children, adolescents, and adults who present with a wide range of emotional stressors. She specializes in Anxiety and is a Certified Clinical Anxiety Treatment Professional (CCATP), ADHD, Depression, Eating Disorders/Body Image and Executive Functioning and Leadership Training. Dr. Muradian is also a specialist in Psychological, Personality and Neuropsychological Assessments. Dr. Muradian is fluent in French, Romanian, and incorporates her multicultural background and experiences in her clinical practice and trainings. Her focus is on helping people find their passion through exploring their inner strengths and bring these to the surface. There is no age limit to success as it all starts with an idea. How you generate and create that idea is the path to ultimate success. Dr. Muradian has been featured as a national renowned parent expert in outlets not limited to: Good Day LA, UK Talk Radio, WFLA Channel 8, Architectural Digest, FabFitFun, Huffington Post, MSN, CV Weekly, Thrive Global, and Healthline. About National Debt Relief: National Debt Relief (NDR), a BBB A+ Accredited business that helps consumers get out of debt and is committed to empowering people on their financial journey, bringing them back to living their lives and away from focusing on debt. NDR offers a successful alternative to bankruptcy, credit counseling or taking on new loans. As a top-rated debt relief company in the U.S., NDR is proud to have positively impacted the lives of hundreds of thousands of people on their journey to become debt-free. NDR wants to make sure clients succeed and have the best chance to regain control of their finances. Founded in 2009, NDR is values-centric; built on integrity, growth and connection. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

May 09, 2022 01:00 PM Eastern Daylight Time

Video
Article thumbnail News Release

Telos “Mission” NFT Challenge - 175,000 in Crypto Prizes!

Telos Foundation

Telos Blockchain (ticker: TLOS) presents its “Mission NFT Challenge” for digital graphic creators, offering a very attractive prize pool to be shared among contest winners. Telos believes that NFTs are both an art form and a pivoting technology that should be easily and affordably accessible to the masses. As such, Telos strives to facilitate the lowest barrier of entry into the emerging field of NFTs. Utilizing Byt.io, the latest leading NFT marketplace to integrate Telos, end-users will mint and trade their NFTs at unprecedented fast speeds while enjoying industry-low gas fees. The Telos EVM will also offer a congestion-free minting experience that leaves no carbon footprint or any of the front running / MEV that constantly plagues Ethereum users. Furthermore, contract deployment is a fraction of the cost and significantly faster on Telos when compared to virtually every other network, making it a far superior ecosystem to build on. Transactions are instant on Telos! Some Contest Details: The contest opens for registration on Monday May 9th, 12:00 pm EST and participants can submit their projects by Friday, June 24th, 12:00 pm EST. Public Voting on the submissions will take place between Monday May 23rd, 12:00 pm EST to Thursday, June 30th, at 12:00 pm EST. Twenty finalists will be announced on Friday July 1st, 12:00 pm EST and the top five winners will be selected and announced on Tuesday July 5th at 11:00 am EST. Telos encourages all digital artists and aspiring NFT projects to compete in this contest to win one of 5 prizes worth 25,000 TLOS each. Furthermore, an honorable pick by The Big Gooey, Telos’ in-house NFT curator, will award one winner with an additional 50,000 TLOS. The contest and voting will be hosted on the Taikai platform (also built on telos), which recently completed a very successful hackathon for the Telos Ignite contest. The public will vote on all submissions to select the top 20 projects after which a panel of judges will decide on the top five. This maiden NFT contest is inviting artists to bring their NFT projects (ERC 721) and deploy them on the tEVM where they can be minted to be sold on the Byt marketplace or other secondary markets. All additional details and criteria can be found on the Taikai platform through the following link: https://taikai.network/en/telos-foundation/hackathons/nftp-slug/overview About Telos Live since 2018, Telos Blockchain (ticker: TLOS) is a third-generation smart contract platform that offers compatibility with Solidity, Vyper, and Native C++ smart contracts. Telos provides full EVM/Solidity support with fixed low-cost gas fees and no front running and, more uniquely, offers a path to fee-less transactions via its robust native C++ smart contract support. Even while operating as a Net Zero Blockchain, Telos still sustainably supports hundreds of millions of transactions per day, produces blocks in 0.5 second intervals (on a first-in-first-out basis, eliminating front running on the network), and securely validates transactions via a credibly neutral and globally decentralized block producer network. As a result, the Telos blockchain has the throughput needed to facilitate and scale the thriving Metaverse / Web 3.0 landscape better than any other blockchain in existence. Its performance is unrivaled in the industry and was purpose-built to offer speed, scalability, cost-effectiveness, credible decentralization, and end-user fairness. Telos harnesses its power by utilizing tight C++ on the frontend and a custom WASM runtime environment on the backend. About The Foundation The Telos Foundation is a Decentralized Autonomous Organization established as a promotional and funding body to advance the Telos Blockchain Network and provide support to network applications. Contact Details The Team hello@telosfoundation.io Telos NFT Curator The Big Gooey thebiggooey@telosfoundation.io Byt Co-founder Will Perkins will@byt.io Company Website https://www.telos.net/

May 09, 2022 11:06 AM Eastern Daylight Time

Video
Article thumbnail News Release

Web3 Solidity Engine, tEVM 2.0 - Ahead of Schedule

Telos Foundation

As the Goliaths of crypto continuously crash ( Solana ), fail to deliver ( Ethereum ), or live in their white papers ( Cardano ), David ( Telos ) continues to defy them all and over-deliver. The Telos story is very much a David vs. Goliath story. Why? Because Telos is tens and even hundreds of billions of dollars smaller than its peers in market cap, yet still manages to significantly lead them in speed, costs, true capacity, credible neutrality, front running protection, fair governance, and energy efficiency ( Net Zero ). The tEVM Version 1.0's capabilities are already a quantum leap ahead of its peers and are clearly demonstrated in this video. Now, less than a year later, version 2.0 is set to elevate the tEVM's performance further. Jesse Schulman (Lead Architect and TCO), alongside Kersten Wirth (Program Manager), will be providing detailed insights into the development of Telos EVM 2.0. This hybrid "Super-Node" solution will be even easier to operate and integrate than the previous version, offer top-notch history management, and tie in with the best available Ethereum clients. The dev-duo will also be discussing the many benefits and successes of the existing tEVM Version 1. Since its launch, the tEVM’s ecosystem is closing on six months of strategic growth. On the DeFi side, it has already launched multiple Dex/AMMs, Price Oracles, Farming dApps, multi-Chain bridges, Lending dApps, and everything else that a vibrant DeFi ecosystem requires to level up its TVL and end-user occupancy. Telos’ TVL is now where the market cap leading chains were not long ago but with far superior governance, no front running, credible neutrality, true decentralization, and an ESG compliant EVM that is several multiples faster. In utopian fashion, Telos’ ecosystem is now ready to scale its occupants and its TVL simultaneously. About Telos Live since 2018, Telos Blockchain (ticker: TLOS) is a third-generation smart contract platform that offers compatibility with Solidity, Vyper, and Native C++ smart contracts. Telos provides full EVM/Solidity support with fixed low-cost gas fees and no front running and, more uniquely, offers a path to fee-less transactions via its robust native C++ smart contract support. Even while operating as a Net Zero Blockchain, Telos still sustainably supports hundreds of millions of transactions per day, produces blocks in 0.5 second intervals (on a first-in-first-out basis, eliminating front running on the network), and securely validates transactions via a credibly neutral and globally decentralized block producer network. As a result, the Telos blockchain has the throughput needed to facilitate and scale the thriving Metaverse / Web 3.0 landscape better than any other blockchain in existence. Its performance is unrivaled in the industry and was purpose-built to offer speed, scalability, cost-effectiveness, credible decentralization, and end-user fairness. Telos harnesses its power by utilizing tight C++ on the frontend and a custom WASM runtime environment on the backend. About The Foundation The Telos Foundation is a Decentralized Autonomous Organization established as a promotional and funding body to advance the Telos Blockchain Network and provide support to network applications. Not investing advice. Contact Details The Team hello@telosfoundation.io Company Website https://www.telos.net/

May 04, 2022 01:00 PM Eastern Daylight Time

Video Image
Article thumbnail News Release

Hong Kong Baptist University joint research reveals that gut microbial enzymes reactivate triclosan which induces colitis

Hong Kong Baptist University

HONG KONG SAR - Media OutReach - 3 May 2022 - A Hong Kong Baptist University (HKBU) collaborative research study has revealed that certain gut microbial enzymes mediate the reactivation of triclosan (TCS) from its inactive glucuronide metabolite. TCS is an antimicrobial agent commonly used in a wide range of consumer products, and it is associated with the development of colitis. Professor Cai Zongwei, Chair Professor of the Department of Chemistry and Director of the State Key Laboratory of Environmental and Biological Analysis at HKBU, points out that according to the research results specific gut microbial enzymes drive the conversion of TCS metabolites to TCS which increases the chance of developing colitis. The research results have been published in Nature Communications, an international scientific journal. Mechanism of TCS exposure leading to colitis previously unclear TCS is widely used as an antimicrobial agent in consumer products such as toothpaste, mouthwash, hand sanitisers, cosmetics and toys. It is a major environmental contaminant, and it has been shown that TCS exposure increases the risk of colitis. Once TCS enters the human body, it is rapidly metabolised to form the biologically inactivemetabolite TCS-glucuronide (TCS-G), which is easily eliminated from the body. Due to this characteristic, the mechanism of how environmental exposure to TCS leads to gut toxicity in the human body has previously remained unclear. To answer this question, a research team co-led by Professor Cai Zongwei, Chair Professor of the Department of Chemistry and Director of the State Key Laboratory of Environmental and Biological Analysis at HKBU; Professor Matthew R Redinbo from the University of North Carolina at Chapel Hill; and Professor Zhang Guodong from the University of Massachusetts Amherst conducted a research study based on the hypothesis that certain gut microbial enzymes act on TCS-G in the gut, leading to the reactivation of TCS and the subsequent development of colitis. TCS concentration uniquely high in the gut To begin with, the research team sought to determine whether the gut has a different TCS metabolic profile compared to other body tissues. A group of mice were fed food that contained TCS. After four weeks, it was found that the biologically inactive TCS-G was dominant in their liver, bile, heart and small intestine, while the colitis-inducing TCS was dominant in the gut (cecum and colon). The results showed that the gut has a uniquely high concentration of TCS compared to other body tissues. The research team then analysed the relationship between TCS-containing products and the concentration of TCS in the human body. In a group of human subjects who used TCS-containing personal care products for four months, both TCS and TCS-G were detected in their stool and urine samples, with TCS being dominant in stool and TCS-G being dominant in urine. However, TCS and TCS-G were not detected in the control group who used TCS-free personal care products. The results showed that the use of TCS-containing products leads to a high level of TCS, specifically in the human gut. Gut microbiota significant in TCS-G conversion The question remains why the human gut has a uniquely high TCS concentration. To answer this, the research team put forth the hypothesis that gut microbiota participate in the conversion of TCS-G to TCS, leading to the accumulation of TCS in the gut. To test this hypothesis, the researchers observed that in an in vitro setting, cultured gut bacteria from both mice and humans were able to catalyse the conversion of TCS-G to TCS. To investigate whether the same phenomenon appears in an in vivo setting, the research team found that the inhibition of gut bacteria from mice by applying an antibiotic treatment almost reduced the concentration of TCS in their guts by half, and it increased the concentration of TCS-G by six-fold. The results affirmed that gut microbiota play a significant role in the conversion of TCS-G to TCS in the gut. Specific enzymes catalyse TCS-G conversion To investigate the mechanism by which gut microbiota catalyse TCS-G conversion, the research team focused on the intestinal β - glucuronidase (GUS) enzymes produced by gut bacteria in both mice and humans, because they have been shown to catalyse a wide range of metabolite conversions. Using a series of screening techniques, two types of GUS, namely “Loop 1” and “flavin mononucleotide (FMN)-binding” GUSs, were found to be most effective at converting TCS-G to TCS in vitro. The research team then applied a GUS inhibitor, a drug that inhibits the function of Loop 1 and FMN-binding GUSs, to TCS-exposed and TCS-free mice. It was found that the GUS inhibitor could curb the conversion of TCS-G to TCS by the GUS enzymes. Colitis in TCS-exposed mice was also relieved after the application of the GUS inhibitor. The results support the notion that specific microbial GUS enzymes drive the conversion of TCS-G to TCS, and as a result, the chance of developing colitis is increased. More stringent TCS controls needed Professor Cai said: “Our research results clearly defined the mechanism by which gut microbiota are involved in the metabolism and toxicology of TCS, and the study offers a way to prevent the development of colitis following environmental exposure to chemicals. “Regulatory bodies should consider imposing more stringent controls on the use of TCS. Although the US Food and Drug Administration (FDA) banned the marketing of TCS in over-the-counter antiseptic products in 2016, the chemical remains approved for use in a wide range of products. Transparency on TCS ingredients in product labelling and illustrations should also be improved so that consumers can be aware of the potential risks and make informed choices.” #HongKongBaptistUniversity #HKBU Contact Details Winnie Shum of the Communication and Public Relations Office +852 3411 5262 hkbunews@hkbu.edu.hk Company Website https://www.hkbu.edu.hk/

May 03, 2022 09:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

CognitiveCare Inc. Receives a Grant of Nearly $1 Million to Advance Maternal and Fetal Health

CognitiveCare

CognitiveCare, a Healthcare AI startup and pioneer in maternal and infant health, today announced it has received a $965,871 grant from the Bill & Melinda Gates Foundation to provide antenatal risk stratification AI support for the ARC’s pregnancy surveillance efforts. According to the World Health Organization (WHO), global maternal mortality is an unacceptably high 810 deaths per day, primarily from preventable or treatable causes. Further, 10–15% of all infants born are preterm and are at increased risk of morbidity and mortality. As part of this grant, CognitiveCare will detect and quantify propensity for critical adverse outcomes during antepartum, intrapartum, and postpartum stages, by leveraging CognitiveCare’s Maternal Infant Health Insights & Cognitive intelligence “ MIHIC ” solution. MIHIC incorporates granular insights and patterns that interplay with clinical and social determinants of health to help detect and quantify risks at individual and population levels. CognitiveCare will first validate its models with local data and will then integrate MIHIC into both the Kenya PRiSMA (western Kenya) and the Aga Khan University & VITAL Pakistan ARC sites’ existing production environments. A segment of this grant is dedicated to train the ARC sites to use MIHIC, ensuring sustainable impact. “With the foundation’s grant support, our aim is to support caregivers in understanding propensity for risk early enough to help reduce maternal and infant morbidity and mortality,” said Dr. Suresh Attili, Co-Founder and Chief Medical Officer, CognitiveCare. “Decisions on patient care rest with physicians; however, risk scores generated by MIHIC support triaging patients early. The models will further provide explainable AI functionality to help caregivers understand the ‘why’ behind each MIHIC Score TM.” “ G iven that 94% of all maternal deaths occur in low- and lower-middle-income countries, CognitiveCare is committed to ensuring that low resource settings have access to MIHIC,” said Sheena Gill, President, Americas for CognitiveCare. “With this grant, we take another important step toward our vision to eradicate maternal and infant mortality globally.” About CognitiveCare: CognitiveCare is working at the forefront of science to build the world's first comprehensive health risk quantification solution that integrates AI, advanced math, and stats at the intersection of medicine, biology, genomics and social determinants. CognitiveCare's MIHIC Score™ platform assesses propensity for risk of maternal, fetal and infant health risks categorized as antepartum, intrapartum and postpartum risk scores early in the pregnancy cycle to empower proactive care. To learn more about CognitiveCare, please visit: www.cognitivecare.com. Contact Details CognitiveCare Vivek Singh vivek@cognitivecare.com Company Website https://cognitivecare.com

May 03, 2022 08:00 AM Eastern Daylight Time

Article thumbnail News Release

MetroPlusHealth And NYC Health + Hospitals', Dr. Eric Wei, Named to City & State's "2022 Power Of Diversity: Asian 100."

MetroPlusHealth

Eric Wei, MD, MBA, Board Member and Chair of the Quality Assurance & Performance Improvement Committee of MetroPlusHealth and Senior Vice President and Chief Quality Officer of NYC Health + Hospitals has been named to City & State’s “2022 Power of Diversity: Asian 100” list. He will be featured in a special edition of City & State published today, recognizing the most influential Asian Americans in New York. The prestigious Asian 100 list has included leaders such as Congress Member Grace Meng, State Senator John Liu, and former Presidential candidate Andrew Yang. “I am honored to be recognized by City & State, and I am proud to see the accomplishments of New York’s vibrant Asian-American community being celebrated on such a prominent platform,” said Dr. Wei. “As challenging as the last two years have been, I am grateful to be a part of a public health care system that is committed to the values of diversity and inclusion. I want to thank my amazing team at NYC Health + Hospitals, colleagues at MetroPlusHealth, and family for their unwavering support.” In addition to Dr. Wei’s achievements, he has been a strong advocate for the Asian American Pacific Islander (AAPI) community. He will be a featured speaker at a May 18 th press conference on the steps of City Hall, addressing the lack of resources and the critical importance of mental health and wellness among AAPI New Yorkers. Dr. Wei was a panelist at the Stop Anti-Asian Hate Crime Town Hall in 2021, hosted by MetroPlusHealth. He presided over the Grand Opening of MetroPlusHealth’s flagship community office in Flushing, Queens, bringing needed resources to the neighborhood’s large Asian population. “Congratulations to Dr. Wei on being recognized as City & State Diversity: Asian 100 recognition,” said Dr. Talya Schwartz, President and CEO of MetroPlusHealth. “Dr. Wei has been an incredible leader and advocate in the AAPI community, especially during the COVID-19 pandemic. His work in creating an equitable future for the health of the AAPI communities is a key component to closing the gaps in health care disparities.” “Dr. Wei is incredibly deserving of this recognition, and we are happy to celebrate this wonderful achievement with him,” said Dr. Mitchell Katz, President and CEO of NYC Health + Hospitals. “Eric’s heroic leadership during the pandemic has solidified him as one of the most influential people in this great city we are so proud to serve.” The special recognition comes at the start of Asian American Pacific Islander Heritage Month and Mental Health Awareness month. In early May, MetroPlusHealth will release the findings of a research project surveying Asian females in New York City about their mental health concerns. Additionally, MetroPlusHealth will partner with community-based organizations providing mental health services to the AAPI community. Dr. Wei will participate in video interviews with these organizations to raise awareness of seeking help to improve mental health and wellness. Dr. Wei’s focus during the pandemic included strategic planning to quadruple ICU capacity, reconfiguring emergency departments to accommodate the needs and patient volume demands and leading the patient level-loading system that moved over 850 COVID-19 patients in the first NYC wave to ensure each hospital was operating safely considering high patient volumes. He also oversaw more than $35 million in donations to the public health system to help with employee accommodations, such as meals, transportation, and childcare. The expansion of the Helping Healers Heal program supports employees’ emotional and psychological well-being. Dr. Wei is the fellowship director for the NYC Health + Hospitals Clinical Leadership Fellowship and launched Healthcare Administration Scholars Program (HASP) across 5 NYC Health + Hospitals sites. He is a practicing Emergency Medicine physician rotating through all 11 Emergency Departments in NYC Health + Hospitals. He serves as faculty for the Greater New York Hospital Association/UHF Clinical Quality Fellowship Program. Dr. Wei received his bachelor’s degree in Molecular, Cell and Developmental Biology at the University of California, Los Angeles, in 2003. He completed the combined MD and MBA program at the University of California, Irvine, in 2009. Dr. Wei completed his Emergency Medicine residency and the Healthcare Administration Scholars Program at the University of Michigan in 2013. He is certified in Lean Healthcare, Six Sigma Black Belt, and TeamSTEPPS Master Trainer. He is a fellow of the American College of Emergency Physicians. Dr. Wei was named to Modern Healthcare’s “50 Most Influential Clinical Leaders” list and Forbes 40 Under 40, both in 2021. As with many New Yorkers, the pandemic has raised the mental health challenges faced by the AAPI community during these difficult times. New York City offers free, private mental health support in Chinese, Japanese, Korean, and more than 200 languages. Support can be accessed 24/7, 365 days a year. To speak to a counselor and get access to services, call 888-NYC-WELL (888-692-9355) or text “WELL” to 65173. City & State Diversity: Asian 100 list: https://www.cityandstateny.com About MetroPlusHealth Since 1985, MetroPlusHealth Plan has built a reputation for providing access to affordable, quality health care to residents across New York City. MetroPlusHealth is the plan of choice for over 600,000 New Yorkers and has a five-star rating based on the State’s 2020 Consumer’s Guide to Medicaid and Child Health Plus Managed Care Plans in New York City. The health plan’s robust network of primary care doctors and specialists includes many independent community providers. Culturally sensitive and fluent in more than 40 languages, MetroPlusHealth’s staff is as diverse as the great city it serves. For more information about MetroPlusHealth plans, benefits, and services, visit www.metroplus.org and join the conversation at facebook.com/metroplushealth and Twitter @metroplushealth. MetroPlusHealth is a wholly-owned subsidiary of NYC Health + Hospitals, the nation’s largest public health system. About NYC Health + Hospitals NYC Health + Hospitals is the largest public health care system in the nation serving more than a million New Yorkers annually in more than 70 patient care locations across the city’s five boroughs. A robust network of outpatient, neighborhood-based primary and specialty care centers anchors care coordination with the system’s trauma centers, nursing homes, post-acute care centers, home care agency, and MetroPlus health plan—all supported by 11 essential hospitals. Its diverse workforce of more than 42,000 employees is uniquely focused on empowering New Yorkers, without exception, to live the healthiest life possible. For more information, visit www.nychealthandhospitals.org and stay connected on Facebook at https://www.facebook.com/NYCHealthSystem or Twitter at @NYCHealthSystem. Contact Details Divendra Jaffar, MetroPlusHealth 212-908-3380/646-952-3243 jaffadi@metroplus.org Company Website https://www.metroplus.org/

May 02, 2022 02:41 PM Eastern Daylight Time

Image
1 ... 161162163164165 ... 223